Ceftazidime how supplied: Difference between revisions
Created page with "__NOTOC__ {{Ceftazidime}} {{CMG}};{{AE}}{{AK}} FORTAZ in the dry state should be stored between 15° and 30°C (59° and 86°F) and protected from light. FORTAZ is a dry, wh..." |
No edit summary |
||
Line 27: | Line 27: | ||
*Equivalent to anhydrous ceftazidime. | *Equivalent to anhydrous ceftazidime. | ||
'''Tazicef''' in the dry state should be stored at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] and protected from light. Tazicef (ceftazidime for injection, USP) is a dry, white to off-white powder supplied in vials as follows: | |||
Vials: equivalent to 1 gram and 2 grams of ceftazidime. | |||
1 gram (tray of 25): NDC 0409-5082-16 | |||
2 gram (tray of 10): NDC 0409-5084-11 | |||
“Piggyback” Vials for IV admixture: equivalent to 1 gram of ceftazidime. | |||
1 gram (tray of 10): NDC 0409-5083-11 | |||
ADD-Vantage® Vials: equivalent to 1 gram and 2 grams of ceftazidime. | |||
1 gram: NDC 0409-5092-16 | |||
2 gram: NDC 0409-5093-11 | |||
Also available as: | |||
Pharmacy Bulk Vials: equivalent to 6 grams of ceftazidime. | |||
6 gram (tray of 10): NDC 0409-5086-11 | |||
'''Ceftazidime for injection''', USP in the dry state should be stored at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] and protected from light. Ceftazidime for Injection, USP is a white to cream-colored crystalline powder supplied in Pharmacy Bulk Package Bottles as follows: | |||
[[image:Ceftainj.png]] | |||
* | |||
Equivalent to anhydrous ceftazidime. | |||
==References== | ==References== |
Revision as of 17:50, 30 December 2013
Ceftazidime |
---|
FORATZ®,TAZICEF®,CEFTAZIDIME® FDA Package Insert |
Description |
Clinical Pharmacology |
Microbiology |
Indications and Usage |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Overdosage |
Dosage and Administration |
Compatibility and stability |
Directions for use |
How Supplied |
Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
FORTAZ in the dry state should be stored between 15° and 30°C (59° and 86°F) and protected from light. FORTAZ is a dry, white to off-white powder supplied in vials as follows:
NDC 0173-0377-10 500-mg* Vial (Tray of 10)
NDC 0173-0378-10 1-g* Vial (Tray of 10)
NDC 0173-0379-34 2-g* Vial (Tray of 10)
NDC 0173-0382-37 6-g* Pharmacy Bulk Package (Tray of 6)
NDC 0173-0434-00 1-g ADD-Vantage® Vial (Tray of 25)
NDC 0173-0435-00 2-g ADD-Vantage® Vial (Tray of 10)
(The above ADD-Vantage vials are to be used only with Abbott ADD-Vantage diluent containers.)
FORTAZ frozen as a premixed solution of ceftazidime sodium should not be stored above -20°C. FORTAZ is supplied frozen in 50-mL, single-dose, plastic containers as follows:
NDC 0173-0412-00 1-g* Plastic Container (Carton of 24)
NDC 0173-0413-00 2-g* Plastic Container (Carton of 24)
- Equivalent to anhydrous ceftazidime.
Tazicef in the dry state should be stored at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] and protected from light. Tazicef (ceftazidime for injection, USP) is a dry, white to off-white powder supplied in vials as follows:
Vials: equivalent to 1 gram and 2 grams of ceftazidime.
1 gram (tray of 25): NDC 0409-5082-16
2 gram (tray of 10): NDC 0409-5084-11
“Piggyback” Vials for IV admixture: equivalent to 1 gram of ceftazidime.
1 gram (tray of 10): NDC 0409-5083-11
ADD-Vantage® Vials: equivalent to 1 gram and 2 grams of ceftazidime.
1 gram: NDC 0409-5092-16
2 gram: NDC 0409-5093-11
Also available as:
Pharmacy Bulk Vials: equivalent to 6 grams of ceftazidime.
6 gram (tray of 10): NDC 0409-5086-11
Ceftazidime for injection, USP in the dry state should be stored at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] and protected from light. Ceftazidime for Injection, USP is a white to cream-colored crystalline powder supplied in Pharmacy Bulk Package Bottles as follows:
Equivalent to anhydrous ceftazidime.
References
http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050578s053,050634s020lbl.pdf